mianserin has been researched along with Opioid-Related Disorders in 3 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
Opioid-Related Disorders: Disorders related to or resulting from abuse or misuse of OPIOIDS.
Excerpt | Relevance | Reference |
---|---|---|
"Mianserin (or placebo) was added to the routine medication protocol, during the 3-week in-patient phase of detoxification in a prospective, randomized, double blind, placebo controlled study." | 2.71 | The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study. ( Bar-Hamburger, R; Herman, I; Pick, CG; Schreiber, S; Shamir, D, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zullino, DF | 2 |
Krenz, S | 2 |
Favrat, B | 1 |
Zimmermann, G | 1 |
Bertschy, G | 1 |
Besson, J | 1 |
Herman, I | 1 |
Shamir, D | 1 |
Bar-Hamburger, R | 1 |
Pick, CG | 1 |
Schreiber, S | 1 |
Zimmerman, G | 1 |
Miozzari, A | 1 |
Rajeswaran, R | 1 |
Kolly, S | 1 |
Khazaal, Y | 1 |
2 trials available for mianserin and Opioid-Related Disorders
Article | Year |
---|---|
The efficiency of a carbamazepine-mianserin combination scheme in opiate detoxification.
Topics: Adult; Analgesics, Non-Narcotic; Antidepressive Agents, Second-Generation; Carbamazepine; Drug Evalu | 2004 |
The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
Topics: Analysis of Variance; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Double | 2005 |
1 other study available for mianserin and Opioid-Related Disorders
Article | Year |
---|---|
Topiramate in opiate withdrawal- comparison with clonidine and with carbamazepine/mianserin.
Topics: Adrenergic alpha-Agonists; Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Carbama | 2004 |